Market News How it works Learn FAQ
| RCT 0.1222 60.58% | NU 12.375 -18.37% | EWZ 33.44 -21.48% | TGL 0.2449 10.56% | BBD 2.87 -29.48% | SRTM 0.3384 -21.36% | ITUB 7.555 -21.87% | AZTR 1.72 140.56% | XP 15.775 -48.13% | NVD 4.02 -4.06% | SHFS 0.0979 -26.06% | SPCX 148.81 0.89% | CLRO 4.75 46.15% | SOXL 90.94 8.83% | GCDT 0.1442 -18.11% | PBR 22 -15.90% | NWGL 0.0822 0.24% | VALE 11.895 -4.07% | TSLL 10.9402 12.09% | INTC 90.94 4.58% | SGRY 23.095 46.63% | CRWV 56.79 4.71% | NVDA 215.6 2.20% | BITO 10.6301 -1.85% | GPUS 0.1862 10.24% | SOXS 47.855 -8.78% | RBNE 0.17 -10.53% | NOK 8.6738 6.56% | ABEV 2.78 -15.76% | RWM 14.455 -0.65% | IREN 26.12 4.88% | JBLU 2.2648 -13.72% | INTR 4.525 -37.07% | TSLG 5.4701 12.32% | SBS 4.615 -27.89% | TQQQ 68.649 3.56% | XTND 2.1 18.64% | SPRC 1.5 37.61% | SPDN 8.4901 -0.58% | TSLA 395.035 6.13% | AAL 12.1593 0.41% | LUCD 0.5437 32.29% | SID 0.9326 -20.97% | SQQQ 38.275 -3.54% | PBR-A 19.3171 -17.90% | CIFR 7.9 -0.50% | GGB 4.725 -7.35% | T 21.035 0.50% | QID 14.195 -2.44% | NFLX 63.265 -3.93%
OMOutset Medical, Inc. logo

Outset Medical, Inc. (OM)

NASDAQ Global Select · Currency in USD
$4.07 ▼ -0.04 (-0.85%)
As of Oct 26, 1:20 PM ET. Market open.

Summary

Previous Close
$4.10
Open
$4.08
Day's Range
$4.00 – $4.11
52 Week Range
$2.84 – $14.87
Volume
25,638
Avg. Volume
188,765
Market Cap
$76.41M
Beta (5Y Monthly)
1.99
PE Ratio (TTM)
--
EPS (TTM)
-$3.99
Earnings Date
Nov 4, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$14.00

Profile: Outset Medical, Inc.

Sector
Healthcare
Industry
Medical - Devices
Full-time employees
310
CEO
Leslie L. Trigg

Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to deliver dialysis treatment in various environments, including hospitals and patients' homes. This innovative system boasts integrated water purification, on-demand production of dialysate, and advanced software complete with connectivity features.

Earnings

Next report: Wed, Nov 4, 2026
EPS estimate -$0.64 · Revenue est. $31.40M
DateEst.Actual
Aug 6, 2026-$0.72-$0.80Miss
May 7, 2026-$0.79-$0.83Miss
Feb 11, 2026-$0.67-$0.84Miss
Nov 10, 2025-$0.66-$0.69Miss
Aug 6, 2025-$0.98-$0.84Beat
May 7, 2025-$0.95-$3.24Miss

Analyst view

Consensus price target
$14.00 ▲ +244.4%
Range $6.00 – $34.00
Rating: Buy
Buy 64% · Hold 27% · Sell 9%

Get free alerts on OM and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.